Mirae Asset Global Investments Co., Ltd. Exact Sciences Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 750 shares of EXAS stock, worth $43,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
750Holding current value
$43,582% of portfolio
0.0%Shares
24 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.03 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$921 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$833 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$701 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$388 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...